Scientific Publications

  • Korenbrot JI, Formation, structure, and spectrophotometry of air-water interface films containing rhodopsin. Journal of Membrane Biology 37:235-262, 1977.

    Selmanoff MJ, Pramik-Holdaway MJ, Weiner RI. Concentrations of dopamine and norepinephrine in discrete hypothalamic nuclei during the rat estrous cycle. Endocrinology 99:326-329, 1976.

  • New devices and technology take IOP monitoring to next level. Ophthal Times Feb 08, 2014.

    Managing the odds for good outcomes in glaucoma. Ophthal Times Feb 08, 2014.

    Keynote Lecture: Future of teaching, practice of medicine begins today. Ophthal Times Feb 08, 2014.

    Who’s at risk? Reviewing factors for glaucoma onset. Ophthal Times Feb 07, 2014.

    GRF update: Adaptive optics and glaucoma biomarkers. Ophthal Times Feb 07, 2014.

    Dr. Lindstrom: From building blocks to ophthalmic innovation. Ophthal Times Feb 07, 2014.

    What’s new in glaucoma device, drug therapy advances. Ophthal Times Feb 07, 2014.

    Managing glaucoma with personalized IOP monitoring. Ophthal Times Feb 06, 2014.

    Controlled release, wide application. Nature Biotechnology 14:1078-1079, 1996.

    Pramik MJ (Ed.) Norethindrone: The First Three Decades. (Book) Syntex Laboratories, Palo Alto, CA., 1978.

  • (i.e., Articles written by M.J. Pramik for the authors)

    Verta P. Evolution of Carotid Artery Stenting. In process. June 2011.

    Gradishar W. Landmark Trials in Endocrine Adjuvant Therapy for Breast Carcinoma Cancer 2006;106:975–81.

    Sobel JD. Managing vulvovaginal candidiasis. The Female Patient 25:77-81, 2000.

    Wisniewski R. Developing large-scale cryopreservation systems for biopharmaceutical products. BioPharmaceutics 11:50-56, 1998.

    Carlson RH, Garnick RL, Jones AJS, Meunier AM. The determination of recombinant human tissue-type plasminogen activator activity by turbidimetry using a microcentrifugal analyzer. Analytical Biochemistry 168:428-435, 1988.

  • The Essential HEDIS 2000 for Diabetes. A Consolidated Program for Managed Care Organizations. LifeScan Inc. ©2000. Developed, researched and wrote all materials for the program.

    Physician’s Tools for Enhancing Quality of Care. The Essential HEDIS 2000 for Diabetes. LifeScan Inc. ©2000. Developed, researched and wrote all materials for the program

    Tools for Enhancing Diabetes Quality Care (patient education materials). LifeScan Inc. ©2000. Developed, researched and wrote all materials for the program

    Synarel® (nafarelin acetate) Nasal Solution 2 mg/ml. Product Monograph. Syntex Laboratories, Inc. Palo Alto, CA ©1990.

    Transitions. A Journal for Adolescent Medicine. For Syntex Laboratories, Palo Alto, CA. Editor for the publication. Assigned articles, recruited physician/expert authors, wrote articles, edited the manuscripts, and worked with art directors to publication. 1978-1980.

  • Polymers in the Health Care Industry. Spectrum, Decision Resources, Inc., Waltham, MA 1998.

    Hydrogels. Spectrum, Decision Resources, Inc., Waltham, MA 1996.

    Drug Delivery Systems. Decision Resources, Inc., Waltham, MA 1994.

  • Biopharmaceutical firms changing strategies. Practical issues of human genome paradigm being realized. Genetic Engineering News 22:8-10, 46, 2002.

    Gura T. Genomic tools help simplify complex diseases. [MJ Pramik contributed to this article.] In: Inside Genomics: Perspectives. IncyteGenomics Web Journal, 2001.

    Recombinant human growth hormone. One of biotech’s first products expands indications. Genetic Engineering News 20:15, 27, 32, 1999.

    Interleukin-2 therapy boosts CD4+ counts in AIDS patients. Hospital Pharmacist Report 12:12, 1998.

    Cryopreservation technologies. Applications in large volumes of biopharmaceutical products. Genetic Engineering News 18:8-10 1998.

    Recombinant IL-2 therapies in the clinic for cancer and HIV. Genetic Engineering News 18:1, 8, 20, 34, 1997.

    Debate on salt intake peppers meeting of hypertension group. The BBI Newsletter August:159-160, 1997.

    ICH moves toward standard for clinical data. Genetic Engineering News 17 (April 15):1, 31, 1997.

    ICH stability guidelines go to phase 4 documentation. Genetic Engineering News 17 (November 15):1, 38-39, 1976.

    Drug delivery firms focus on controlled release techniques. Genetic Engineering News 17(October 1):1, 38 40, 1996.

    Novel cancer therapies presented at the 37th annual meeting of the American Society of Hematology. Cancer Watch 5:26-28, 1996.

    Getting the total picture. New software to enhance management of diabetes. Drug Topics 140:84, 1996.

    AIDS Conference Bulletin Sixth International Conference on AIDS. 1990.

    FDA council supports congressional mandate to accelerate new drug approval process. Genetic Engineering News 9:1, 15, 36, 1989.

  • The Cytokine Detectives. California Pacific Currents, California Pacific Medical Center, San Francisco, CA, 1994.

    The Knees’ Shock Absorbers: Meniscus Transplant. California Pacific Currents, California Pacific Medical Center, San Francisco, CA, 1994.

    Unraveling the Mysteries of ALS. California Pacific Currents, California Pacific Medical Center, San Francisco, CA, 1994.

    Human Growth Hormone. Helping Short Children Grow. Your World Biotechnology and You. A publication of the Pennsylvania Biotechnology Association, 1992.

    Toys and Creative Play. Good Housekeeping, April, 1985.